ChinaBulls
Request access
Close

ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd宜明昂科

Biotech/Healthcare

Yimingangke is a developer of tumor immunotherapy products, dedicated to the research and development of cancer immunotherapy products, including monoclonal antibodies against immune-regulatory targets and armed, target-specific NK cells.

Source: ChinaBulls — chinabulls.com

Last updated 2021-12-01

Funding Rounds

  • Series C Extension
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd Fundraising Info

Company fundraising information requires an account.

ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd Investors and Backers

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP